Immunotherapy

Cancer imposes continuous challenges on global health, and the trend of its incidence will make it the leading cause of mortality in the twenty-first century (Robert, Vries & Hans 2010). Therefore, identifying novel-cancer antigens that can be used as biomarkers and targets for therapeutics has been a priority to minimize cancer morbidity and mortality rates (Grizzi et al. 2007)